CUSTOMS AND EXCISE LEGISLATION AMENDMENT ACT 1990 No. 111 of 1990 - SCHEDULE 1
CUSTOMS AND EXCISE LEGISLATION AMENDMENT ACT 1990 No. 111 of 1990 - SCHEDULE 1
SCHEDULE 1 Section 35
NEW SCHEDULE VI TO BE SUBSTITUTED FOR CURRENT SCHEDULE
VI TO THE CUSTOMS ACT 1901
"SCHEDULE VI
Section 4
Column 1 Column 2 Column 3
Substance Trafficable Commercial
quantity quantity
(grams) (kilograms)
ACETORPHINE 2.000
ACETYL-ALPHA-METHYLFENTANYL 0.005 0.005
ACETYLCODEINE 2.0
ACETYLDIHYDROCODEINE 2.0
ACETYLMETHADOL 2.0
ALLYLPRODINE 2.0
ALPHACETYLMETHADOL 10.0
ALPHAMEPRODINE 0.2
ALPHAMETHADOL 0.2
ALPHA-METHYLFENTANYL 0.005 0.005
ALPHA-METHYLTHIOFENTANYL 0.005 0.005
ALPHAPRODINE 25.0
AMPHECOLORAL 2.0
3- (2-AMINOPROPYL) INDOLE 2.0
AMPHETAMINE 2.0
ANILERIDINE 25.0
BARBITURATES 50.0
BENZETHIDINE 10.0
BENZYLMORPHINE 5.0
BETACETYLMETHADOL 5.0
BETA-HYDROXYFENTANYL 0.005 0.005
BETA-HYDROXY-3-METHYLFENTANYL 0.005 0.005
BETAMEPRODINE 5.0
BETAMETHADOL 5.0
BETAPRODINE 5.0
BEZITRAMIDE 5.0
4-BROMO-2, 5-
DIMETHOXYAMPHETAMINE 0.5
BUFOTENINE 2.0
CANNABINOIDS 2.0
CANNABIS 100.0 100.0
CANNABIS RESIN 20.0 50.0
CHLORPHENTERMINE 2.0
CLONITAZENE 5.0
COCAINE 2.0 2.0
CODEINE 10.0
CODEINE-N-OXIDE 10.0
CODOXIME 10.0
DESOMORPHINE 2.0
DIAMPROMIDE 5.0
DIETHYLPROPION 5.0
DIETHYLTHIAMBUTENE 5.0
N, N-DIETHYLTRYPTAMINE 2.0
DIHYDROCODEINE 10.0
DIHYDROMORPHINE 10.0
DIMENOXADOL 10.0
DIMEPHEPTANOL 10.0
2, 5-DIMETHOXY-4-METHYLAMPHETAMINE 2.0
DIMETHYLTHIAMBUTENE 20.0
N, N-DIMETHYLTRYPTAMINE 2.0
DIOXAPHETYL BUTYRATE 2.0
DIPHENOXYLATE 2.0
DIPIPANONE 10.0
ECGONINE 10.0
ETHYLMETHYLTHIAMBUTENE 10.0
ETHYLMORPHINE 2.0
ETONITAZENE 5.0
ETORPHINE 5.0
ETOXERIDINE 5.0
FENTANYL 0.005
FURETHIDINE 1.0
HARMALINE 2.0
HARMINE 2.0
HEROIN 2.0 1.5
HYDROCODONE 2.0
HYDROMORPHINOL 2.0
HYDROMORPHONE 2.0
HYDROXYAMPHETAMINE 2.0
HYDROXYPETHIDINE 5.0
KETOBEMIDONE 2.0
LEVORPHANOL 1.0
LYSERGAMIDE 0.1
LYSERGIC ACID 0.002 0.002
LYSERGIDE 0.002 0.002
MESCALINE 7.5
METAZOCINE 7.0
METHADONE 2.0
METHAQUALONE 50.0
METHORPHAN 2.0
METHYLAMPHETAMINE 2.0
3, 4-METHYLENEDIOXYAMPHETAMINE 0.5
3, 4-METHYLENEDIOXYMETHAMPHETAMINE 0.50 0.50
METHYLDESORPHINE 2.0
METHYLDIHYDROMORPHINE 2.0
3-METHYLFENTANYL 0.005 0.005
METHYLPHENIDATE 2.0
1-METHYL-4-PHENYL-4-PROPIONOXYPIPERIDINE
(MPPP)
3-METHYLTHIOFENTANYL 0.005 0.005
METOPON 2.0
MONOACETYLMORPHINES 2.0
MORAMIDE 2.0
MORPHERIDINE 2.0
MORPHINE 2.0 1.5
MORPHINE-N-OXIDE 2.0
MYROPHINE 20.0
NICOCODINE 2.0
NICODICODINE 2.0
NICOMORPHINE 2.0
NORACYMETHADOL 2.0
NORCODEINE 2.0
NORLEVORPHANOL 2.0
NORMETHADONE 5.0
NORMORPHINE 20.0
NORPIPANONE 10.0
OPIUM 20.0 20.0
OXYCODONE 5.0
OXYMORPHONE 2.0
PARA-FLUOROFENTANYL 0.005 0.005
PENTAZOCINE 20.0
PETHIDINE 10.0
PHENADOXONE 10.0
PHENAMPROMIDE 10.0
PHENAZOCINE 1.0
PHENDIMETRAZINE 5.0
PHENMETRAZINE 5.0
PHENOMORPHAN 5.0
PHENOPERIDINE 1.0
1-PHENYLETHYL-4-PHENYL-4-ACETOXYPIPERIDINE
(PEPAP) 2.0 2.0
PHOLCODINE 5.0
PIMINODINE 10.0
PIPRADROL 1.0
PIRITRAMIDE 1.0
PROHEPTAZINE 1.0
PROPERIDINE 25.0
PSILOCIN 0.1
PSILOCYBIN 0.1
TETRAHYDROCANNABINOLS 2.0 5.0
THEBACON 2.0
THEBAINE 2.0
THIOFENTANYL 0.005 0.005
TRIMEPERIDINE 10.0
A substance ("drug analogue") which is,
in relation to another substance (being
a substance specified elsewhere in this
Schedule, or a stereoisomer, a structural
isomer (with the same constituent groups)
or an alkaloid of such a substance): -
(a) a stereoisomer; or
(b) a structural isomer having the same constituent
groups; or
(c) an alkaloid; or
(d) a structural modification obtained in 1 or more
of the following ways:
(i) by the replacement of up to 2 carbocyclic or
heterocyclic ring structures with different carbocyclic or heterocyclic
ring structures;
(ii) by the addition of hydrogen atoms to 1 or
more unsaturated bonds;
(iii) by the addition of 1 or more of the
following groups, namely alkoxy, cyclic diether, acyl, acyloxy, mono-amino
and dialkylamino groups with up to 6 carbon atoms in any alkyl residue;
alkyl, alkenyl and alkynyl groups with up to 6 carbon atoms in the group,
where the group is attached to oxygen (for example, an ester or an ether
group), nitrogen, sulphur or carbon; and halogen, hydroxy, nitro and amino
groups;
(iv) by the replacement of 1 or more of the groups
specified in subparagraph (iii) with another such group or groups;
(v) by the conversion of a carboxyl or an ester
group into an amide group; or
(e) otherwise an homologue, analogue, chemical
derivative or substance substantially similar in
chemical structure;
however obtained, except where the drug analogue is
separately specified in this Schedule The minimum
trafficable
quantity of:
(a) that other
substance in
relation to
which the
substance is a
drug analogue; or
(b) if there is
more than 1 such
other substance -
that other
substance having
the least minimum
trafficable quantity
The minimum
commercial
quantity,
if any, of:
(a) that other
substance in
relation to which
the substance is a
drug analogue; or
(b) if there is
more than 1 such
other substance -
that other substance
having the least
minimum commercial
quantity.